ARCH Venture Partners VII, LLC's Net Worth
$672 Million
Who is ARCH Venture Partners VII, LLC?
ARCH Venture Partners VII, LLC has an estimated net worth of $672 Million. This is based on reported shares across multiple companies, which include PHASERX, INC., AGIOS PHARMACEUTICALS INC, Neumora Therapeutics, Inc., Receptos, Inc., 908 Devices Inc., Pulmatrix, Inc., bluebird bio, Inc., Twist Bioscience Corp, Sage Therapeutics, Inc., Unity Biotechnology, Inc., Syros Pharmaceuticals, Inc., and Juno Therapeutics, Inc..
SEC CIK
ARCH Venture Partners VII, LLC's CIK is 0001544443
Past Insider Trading and Trends
2018 was ARCH Venture Partners VII, LLC's most active year for acquiring shares with 15 total transactions. ARCH Venture Partners VII, LLC's most active month to acquire stocks was the month of April. 2014 was ARCH Venture Partners VII, LLC's most active year for disposing of shares, totalling 13 transactions. ARCH Venture Partners VII, LLC's most active month to dispose stocks was the month of April. 2023 saw ARCH Venture Partners VII, LLC paying a total of $25,500,000.00 for 18,924,704 shares, this is the most they've acquired in one year. In 2014 ARCH Venture Partners VII, LLC cashed out on 24,272,413 shares for a total of $1,345,906.01, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PHASERX, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +12.62% | 319.94K |
$2.51 | $4,993,199.41 | 2.85M |
May 23
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
AGIOS PHARMACEUTICALS INC (AGIO) Snapshot price: $23.76
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -11.11% | -386.07K |
—
|
—
| 3.09M |
Feb 19
| |||
Form 4
| -10.00% | -386.07K |
—
|
—
| 3.47M |
Jun 23
| |||
Form 4
|
∞
| 3.86M |
—
|
—
| 3.86M |
Jul 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Receptos, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.03% | -45.38K |
$29.66 | -$1,345,906.01 | 2.19M |
May 13 - May 14
| |||
Form 4
| +1,852.25% | 2.12M |
$14.00 |
—
| 2.23M |
May 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Pulmatrix, Inc. (PULM) Snapshot price: $1.8
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +50.30% | 1.15M |
—
|
—
| 3.44M |
Apr 3
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
∞
| 2.29M |
$6.88 |
—
| 2.29M |
Jun 15 - Jun 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
bluebird bio, Inc. (BLUE) Snapshot price: $0.93305
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.79M |
—
|
—
| 1.79M |
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |